Decreased serum brain-derived neurotrophic factor levels in major depressed patients

Psychiatry Research
Félicien KaregeJean-Michel Aubry

Abstract

Recent findings with animal models have suggested a possible role for brain-derived neurotrophic factor (BDNF) in depression. We have therefore hypothesized that depression could be characterized by low levels of serum BDNF. Major depressed patients (15F + 15M) diagnosed according to DSM-IV criteria and healthy controls (15F + 15M) participated in the study. Serum BDNF was assayed with the ELISA method and the severity of depression was evaluated with Montgomery-Asberg-Depression Rating Scale (MADRS). BDNF levels were significantly lower in patients than in controls: 22.6 +/- 3 and 26.5 +/- 7 ng/ml (t-test = 2.7; d.f. = 58; P < 0.01). They were negatively correlated to the MADRS scores (r = -0.55; P < 0.02). Female patients were more depressed and released less BDNF than men. Analysis of covariance (MADRS and gender as independent variable vs. BDNF as dependent variable) indicated that depression severity mainly accounted for the negative correlation. These results suggest that major depression is characterized by low serum BDNF levels and support the hypothesis of neurotrophic factor involvement in affective disorders.

Associated Clinical Trials

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Nov 3, 1992·European Journal of Pharmacology·Y WatanabeB S McEwen
Jul 1, 1980·Clinics in Endocrinology and Metabolism·A G Pearse
May 1, 1994·Trends in Neurosciences·R M LindsayP S DiStefano
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y I ShelineM W Vannier
Jan 1, 1996·Seikagaku. The Journal of Japanese Biochemical Society·Y FurukawaK Hayashi
Jan 1, 1997·Pharmacology, Biochemistry, and Behavior·J A SiuciakR M Lindsay
Nov 14, 1997·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·L ShenB Lu
Dec 5, 1997·Brain Research. Molecular Brain Research·B ConnorM Dragunow
Oct 31, 1998·Brain Research. Molecular Brain Research·H S OliffC W Cotman
Apr 2, 1999·Trends in Pharmacological Sciences·C A Altar
May 20, 1999·Biological Psychiatry·G RajkowskaC A Stockmeier
Oct 12, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A Russo-NeustadtC W Cotman
Jan 9, 2001·The Psychiatric Clinics of North America·R C Shelton
Jan 13, 2001·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·N DuranyP Riederer

❮ Previous
Next ❯

Citations

Jan 26, 2011·Der Nervenarzt·G PaslakisM Deuschle
Dec 8, 2006·Diabetologia·K S KrabbeB K Pedersen
May 27, 2005·Psychopharmacology·Undine E LangJürgen Gallinat
Feb 11, 2011·Psychopharmacology·Montserrat Serra-MillàsCristóbal Gastó
Jan 3, 2012·Rheumatology International·Boya NugrahaChristoph Gutenbrunner
Mar 23, 2010·European Archives of Psychiatry and Clinical Neuroscience·Cagdas EkerAli Saffet Gonul
Mar 5, 2013·European Archives of Psychiatry and Clinical Neuroscience·E OralN Aydin
Oct 28, 2005·Journal of Neural Transmission·A M HuangH I Chen
Sep 4, 2008·Journal of Neural Transmission·Magdalena Sowa-KućmaGabriel Nowak
Aug 6, 2010·Journal of Neural Transmission·Jucélia J FortunatoJoão Quevedo
Mar 17, 2009·Brain Topography·Lizbeth Cárdenas-MoralesCarlos Schönfeldt-Lecuona
Aug 26, 2009·Neurotoxicity Research·Clarissa M ComimFelipe Dal-Pizzol
May 27, 2009·Archives of Oral Biology·A L MandelV Utermohlen
May 17, 2005·Brain Research. Molecular Brain Research·Félicien KaregeRomano La Harpe
Apr 10, 2009·Psychological Medicine·I JiménezJ Castillo
Aug 26, 2010·Journal of Proteome Research·Mariana D Plazas-Mayorca, Kent E Vrana
Nov 17, 2010·Molecular Psychiatry·B LuscherN Sahir
Aug 6, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Heath D Schmidt, Ronald S Duman
Aug 5, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Heath D SchmidtRonald S Duman
Jun 24, 2008·Nature Reviews. Neuroscience·Fernando Gómez-Pinilla
Feb 23, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Tomi RantamäkiEero Castrén
Sep 14, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Christopher Pittenger, Ronald S Duman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.